Your browser doesn't support javascript.
loading
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Martínez-Cuadrón, David; Boluda, Blanca; Martínez, Pilar; Bergua, Juan; Rodríguez-Veiga, Rebeca; Esteve, Jordi; Vives, Susana; Serrano, Josefina; Vidriales, Belen; Salamero, Olga; Cordón, Lourdes; Sempere, Amparo; Jiménez-Ubieto, Ana; Prieto-Delgado, Julio; Díaz-Beyá, Marina; Garrido, Ana; Benavente, Celina; Pérez-Simón, José Antonio; Moscardó, Federico; Sanz, Miguel A; Montesinos, Pau.
Afiliação
  • Martínez-Cuadrón D; Hematology Department, Hospital Universitari i Politècnic, La Fe, Avinguda Fernando Abril Martorell, 106, 46026, València, Spain.
  • Boluda B; CIBERONC, Instituto Carlos III, Madrid, Spain.
  • Martínez P; Hematology Department, Hospital Universitari i Politècnic, La Fe, Avinguda Fernando Abril Martorell, 106, 46026, València, Spain.
  • Bergua J; Hospital 12 de Octubre, Madrid, Spain.
  • Rodríguez-Veiga R; Hospital San Pedro de Alcántara, Cáceres, Spain.
  • Esteve J; Hematology Department, Hospital Universitari i Politècnic, La Fe, Avinguda Fernando Abril Martorell, 106, 46026, València, Spain.
  • Vives S; Hospital Clinic, Barcelona, Spain.
  • Serrano J; Hospital ICO-Universitari Germans Trias i Pujol, José Carreras, Leukemia Research Institute, Badalona, Spain.
  • Vidriales B; Hospital Reina Sofía, Córdoba, Spain.
  • Salamero O; Hospital Universitario de Salamanca, Salamanca, Spain.
  • Cordón L; Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Sempere A; Hematology Department, Hospital Universitari i Politècnic, La Fe, Avinguda Fernando Abril Martorell, 106, 46026, València, Spain.
  • Jiménez-Ubieto A; CIBERONC, Instituto Carlos III, Madrid, Spain.
  • Prieto-Delgado J; Hematology Department, Hospital Universitari i Politècnic, La Fe, Avinguda Fernando Abril Martorell, 106, 46026, València, Spain.
  • Díaz-Beyá M; CIBERONC, Instituto Carlos III, Madrid, Spain.
  • Garrido A; Hospital 12 de Octubre, Madrid, Spain.
  • Benavente C; Hospital San Pedro de Alcántara, Cáceres, Spain.
  • Pérez-Simón JA; Hospital Clinic, Barcelona, Spain.
  • Moscardó F; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Sanz MA; Hospital Clínico San Carlos, Madrid, Spain.
  • Montesinos P; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Ann Hematol ; 97(5): 923, 2018 05.
Article em En | MEDLINE | ID: mdl-29473097
ABSTRACT
The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández in the original article.The original version of this article was revised The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández.
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha